======= CDCA8 ======= == Gene Information == * **Official Symbol**: CDCA8 * **Official Name**: cell division cycle associated 8 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=55143|55143]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q53HL2|Q53HL2]] * **Interactions**: [[https://thebiogrid.org/search.php?search=CDCA8&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20CDCA8|Open PubMed]] * **OMIM**: [[https://omim.org/entry/609977|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Component of the chromosomal passenger complex (CPC), a complex that acts as a key regulator of mitosis. The CPC complex has essential functions at the centromere in ensuring correct chromosome alignment and segregation and is required for chromatin-induced microtubule stabilization and spindle assembly. Major effector of the TTK kinase in the control of attachment- error-correction and chromosome alignment. {ECO:0000269|PubMed:15249581, ECO:0000269|PubMed:15260989, ECO:0000269|PubMed:16571674, ECO:0000269|PubMed:18243099}. |Nbl1 Borealin N| |Borealin| |chromosome passenger complex| |chromocenter| |spindle midzone| |mitotic metaphase plate congression| |chromosome, centromeric region| |metaphase plate congression| |intercellular bridge| |establishment of chromosome localization| |chromosome localization| |mitotic sister chromatid segregation| |sister chromatid segregation| |mitotic nuclear division| |midbody| |nuclear chromosome segregation| |chromosome segregation| |nuclear division| |organelle fission| |establishment of organelle localization| |cell division| |organelle localization| |protein-containing complex| |mitotic cell cycle process| |mitotic cell cycle| |nucleolus| |cell cycle process| |chromosome organization| |cell cycle| |establishment of localization in cell| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp513|ONC212 0.15μM R08 exp513]]|-3.05| |[[:results:exp25|Oligomycin-A 2μM R00 exp25]]|-2.59| |[[:results:exp487|Hinokiflavone 12μM R08 exp487]]|-2.32| |[[:results:exp469|CFI-400945 25μM R08 exp469]]|-2.29| |[[:results:exp17|DABN 20μM R00 exp17]]|-2.23| |[[:results:exp531|THZ1 0.06μM R08 exp531]]|-2.14| |[[:results:exp527|Tanespimycin 14μM R08 exp527]]|-2.08| |[[:results:exp532|TIC10 10μM R08 exp532]]|-1.94| |[[:results:exp4|Actinomycin-D 0.01μM R00 exp4]]|-1.76| |[[:results:exp431|Rotenone 0.07μM R08 exp431]]|-1.72| |[[:results:exp451|Atovaquone 15μM R08 exp451]]|-1.71| |[[:results:exp503|Mitomycin-C 0.06μM R08 exp503]]|-1.7| |[[:results:exp7|Bortezomib 0.05μM R00 exp7]]|1.98| |[[:results:exp247|UM0130462 0.025 to 0.035μM day4 R05 exp247]]|1.99| |[[:results:exp94|Nocodazole 0.1μM R03 exp94]]|2.29| |[[:results:exp2|5-Fluorouracil 20μM R00 exp2]]|2.32| |[[:results:exp238|Parthenolide 2.5μM R05 exp238]]|2.56| ^Gene^Correlation^ |[[:human genes:a:aurkb|AURKB]]|0.407| Global Fraction of Cell Lines Where Essential: 719/726 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|1/1| |909776.0|1/1| |bile duct|28/28| |blood|28/28| |bone|25/25| |breast|30/33| |central nervous system|56/56| |cervix|4/4| |colorectal|17/17| |esophagus|13/13| |fibroblast|1/1| |gastric|15/15| |kidney|21/21| |liver|20/20| |lung|75/75| |lymphocyte|14/14| |ovary|25/26| |pancreas|24/24| |peripheral nervous system|16/16| |plasma cell|15/15| |prostate|1/1| |skin|24/24| |soft tissue|7/7| |thyroid|2/2| |upper aerodigestive|22/22| |urinary tract|29/29| |uterus|5/5| == Essentiality in NALM6 == * **Essentiality Rank**: 569 * **Expression level (log2 read counts)**: 6.73 {{:chemogenomics:nalm6 dist.png?nolink |}}